The current immunotherapeutic strategies yield limited therapeutic benefits in patients with castration-resistant prostate cancer (CRPC) due to its immunologically "cold" tumor milieu.
Pericytes play a pivotal role in facilitating metastatic dissemination and modulating immune response in malignancies.
Our investigation is designed to decipher the biological effects of pericytes on CRPC and their interactions with the tumor microenvironment.
